Clinical trial • Phase I/II • Oncology
JNJ-90014496 for B-cell non-Hodgkin lymphoma | Non-Hodgkin lymphoma
Phase I/II trial of JNJ-90014496 for B-cell non-Hodgkin lymphoma | Non-Hodgkin lymphoma. 231 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- B-cell non-Hodgkin lymphoma | Non-Hodgkin lymphoma
- Trial Stage
- Phase I/II
Key dates
- Initial CTIS Submission Date
- 16-01-2024
- First CTIS Authorization Date
- 30-04-2024
Trial design
Phase I/II trial across 16 sites in Germany, France, Denmark and others.
- Target Sample Size
- 231
- Trial Duration For Participant
- 1645
Recruitment
- Planned Sample Size
- 231
- Recruitment Window Months
- 54
Geography
- Total Number Of Sites
- 16
- Total Number Of Participants
- 103
Germany
- Earliest CTIS Part Ii Submission Date
- 19-04-2024
- Latest Decision Or Authorization Date
- 06-05-2024
- Processing Time Days
- 17
- Number Of Sites
- 3
- Number Of Participants
- 6
Sites
- Site Name
- Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
- Department Name
- III. Med. Klinik und Poliklinik
- Contact Person Name
- Georg Hess
- Contact Person Email
- georg.hess@unimedizin-mainz.de
- Site Name
- Universitaetsklinikum Essen AöR
- Department Name
- Klinik für Hämatologie und Stammzelltransplantation
- Contact Person Name
- Bastian von Tresckow
- Contact Person Email
- bastian.vontresckow@uk-essen.de
- Site Name
- Universitaetsklinikum Wuerzburg AöR
- Department Name
- Medizinische Klinik und Poliklinik II des Universitaetsklinikums Zentrum Innere Medizin (ZIM)
- Contact Person Name
- Max Topp
- Contact Person Email
- topp_m@ukw.de
France
- Earliest CTIS Part Ii Submission Date
- 07-03-2024
- Latest Decision Or Authorization Date
- 27-05-2025
- Processing Time Days
- 446
- Number Of Sites
- 2
- Number Of Participants
- 4
Sites
- Site Name
- Institut Universitaire Du Cancer Toulouse-Oncopole
- Department Name
- Hematology Department
- Contact Person Name
- Loic YSEBAERT
- Contact Person Email
- ysebaert.loic@iuct-oncopole.fr
- Site Name
- Centre Hospitalier Universitaire De Nantes
- Department Name
- Hematology Department
- Contact Person Name
- Benoit TESSOULIN
- Contact Person Email
- benoit.tessoulin@chu-nantes.fr
Denmark
- Earliest CTIS Part Ii Submission Date
- 15-04-2024
- Latest Decision Or Authorization Date
- 05-05-2026
- Processing Time Days
- 750
- Number Of Sites
- 2
- Number Of Participants
- 36
Sites
- Site Name
- Odense University Hospital
- Department Name
- Haematological Research unit HFE-X OUH
- Contact Person Name
- Jacob Haaber Christensen
- Contact Person Email
- jacob.h.christensen@rsyd.dk
- Site Name
- Rigshospitalet
- Department Name
- Department of Haematology and Phase 1 Unit
- Contact Person Name
- Martin Hutchings
- Contact Person Email
- martin.hutchings@regionh.dk
Italy
- Earliest CTIS Part Ii Submission Date
- 27-10-2025
- Latest Decision Or Authorization Date
- 11-05-2026
- Processing Time Days
- 196
- Number Of Sites
- 3
- Number Of Participants
- 6
Sites
- Site Name
- Humanitas Mirasole S.p.A.
- Department Name
- UOC ONCOEMATOLOGIA
- Contact Person Name
- Stefania Bramanti
- Contact Person Email
- stefania.bramanti@cancercenter.humanitas.it
- Site Name
- Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
- Department Name
- UOC Hematology
- Contact Person Name
- Pier Luigi Zinzani
- Contact Person Email
- pierluigi.zinzani@unibo.it
- Site Name
- Azienda Ospedaliero-Universitaria Ss.Antonio E Biagio E C.Arrigo Alessandria
- Department Name
- Struttura Complessa a Direzione Universitaria di Ematologia
- Contact Person Name
- Marco Ladetto
- Contact Person Email
- marco.ladetto@ospedale.al.it
Spain
- Earliest CTIS Part Ii Submission Date
- 26-04-2024
- Latest Decision Or Authorization Date
- 11-05-2026
- Processing Time Days
- 745
- Number Of Sites
- 4
- Number Of Participants
- 26
Sites
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Hematology
- Contact Person Name
- Pere Barba
- Contact Person Email
- pbarba@vhio.net
- Site Name
- Hospital Clinic De Barcelona
- Department Name
- Hematology
- Contact Person Name
- Pablo Mozas
- Contact Person Email
- mozas@clinic.cat
- Site Name
- Institut Catala D'oncologia
- Department Name
- Hematology Department
- Contact Person Name
- Anna Maria Sureda
- Contact Person Email
- asureda@iconcologia.net
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Hematology
- Contact Person Name
- Daniel Morillo
- Contact Person Email
- dmorillo@startmadrid.com
Netherlands
- Earliest CTIS Part Ii Submission Date
- 24-04-2024
- Latest Decision Or Authorization Date
- 06-05-2026
- Processing Time Days
- 742
- Number Of Sites
- 2
- Number Of Participants
- 25
Sites
- Site Name
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
- Department Name
- Department of Hematology
- Contact Person Name
- Yasmina Serroukh
- Contact Person Email
- secretariaat.hematologie@erasmusmc.nl
- Site Name
- Universitair Medisch Centrum Utrecht
- Department Name
- Department of Hematology
- Contact Person Name
- Margot Jak
- Contact Person Email
- hemat-research@umcutrecht.nl
Sponsor
Primary sponsor
- Full Name
- Janssen - Cilag International
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Belgium
Investigational products
- Investigational Product Name
- JNJ-90014496
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)